[Generation change in beta-Interferon announced].
R
R
Froböse
D000276:Adjuvants, Immunologic / Q000235:genetics / Q000493:pharmacokinetics / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D001682:Biological Availability; D002478:Cells, Cultured; D005821:Genetic Techniques; D005858:Germany; D006801:Humans; D016899:Interferon-beta / Q000235:genetics* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010330:Patents as Topic; D010597:Pharmacogenetics
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D016899:Interferon-beta